7Richardson P,Mckenna WM,Bristow M,et al.Report of 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies [J].Circulation,1996,93(6):841-842.
8Dini FL,Dell'Anna R,Micheli A,et al.Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy [J].Am J Cardiol,2000,85(12):1455-1460.
9Wallukat G,Podlowski S,Nissen E,et al.Function and structural characterization of anti-beta1- adrenoceptor auto-antibodies of spontaneously hypertensive rats [J].Mol Cell Biochem,2003,251(1-2):67-75.
10De Maria R,Di Lenarda A,Gavazzi A,et al.Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome [J].Ital Heart J,2001,2:130-138.
